Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-04 @ 12:23 AM
Study NCT ID:
NCT03328104
Status:
COMPLETED
Last Update Posted:
2023-07-21
First Post:
2017-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma
Sponsor:
Emory University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-24
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-29
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-20
First Submit QC Date:
None
Study First Post Date:
2017-11-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-20
Last Update Post Date:
2023-07-21
Last Update Post Date Type:
ACTUAL